Understanding DKA and Its Pathophysiology

Diabetic ketoacidosis (DKA) is an acute, life-threatening metabolic complication of diabetes mellitus, most commonly type 1 diabetes but occasionally occurring in type 2 diabetes during severe illness or stress. The underlying mechanism involves an absolute or relative deficiency of insulin coupled with an excess of counter-regulatory hormones such as glucagon, cortisol, and growth hormone. This hormonal imbalance triggers uncontrolled lipolysis, leading to massive production of free fatty acids, which the liver converts into ketone bodies (acetoacetate, beta-hydroxybutyrate, and acetone). The accumulation of these acidic ketones depletes bicarbonate reserves and produces a high-anion-gap metabolic acidosis.

Recognizing DKA early is critical because delayed treatment can rapidly progress to cerebral edema, cardiac arrhythmias, and death. However, many of its hallmark features—such as polyuria, polydipsia, nausea, vomiting, abdominal pain, and altered mental status—overlap with other metabolic emergencies. For instance, hyperosmolar hyperglycemic state (HHS) also presents with profound hyperglycemia and dehydration, while lactic acidosis shares rapid breathing and acidemia. Differentiating these conditions requires a systematic evaluation of laboratory data, clinical history, and physical exam findings.

Classic DKA Presentation

The classic symptom triad of DKA includes polyuria, polydipsia, and weight loss, evolving over hours to a few days. As ketone levels rise, patients develop nausea, vomiting, and diffuse abdominal pain, which can mimic an acute surgical abdomen. The compensatory hyperventilation (Kussmaul respirations) produces deep, rapid breathing as the body attempts to excrete carbon dioxide to buffer acidosis. A distinctive fruity odor of acetone on the breath is a late sign that strongly suggests DKA. Neurologically, patients may range from alert to lethargic or comatose, primarily due to the combined effects of acidosis, hyperosmolality, and electrolyte disturbances.

Importantly, the absence of hyperglycemia does not rule out DKA. Euglycemic DKA, increasingly reported with SGLT2 inhibitor use, presents with near-normal blood glucose levels (<250 mg/dL) but significant ketosis and acidosis. This variant makes clinical suspicion even more reliant on other metabolic parameters such as serum ketones and blood pH.

Overview of Other Metabolic Disorders

Hyperosmolar Hyperglycemic State (HHS)

HHS shares the hyperglycemia and dehydration of DKA but lacks significant ketosis and acidosis. Typically seen in older adults with type 2 diabetes, HHS evolves more slowly (days to weeks) and presents with extreme hyperglycemia (often >600 mg/dL), profound osmotic diuresis, and volume depletion. Neurological symptoms such as lethargy, confusion, or coma are common, but Kussmaul respirations and fruity breath are absent. The primary metabolic derangement is hyperosmolality rather than acidosis, so serum pH remains above 7.3 and bicarbonate above 15 mEq/L. Differentiating HHS from DKA is essential because the treatment emphasis shifts from correcting acidosis to rehydration and gradual glucose lowering, with careful attention to preventing osmotic shifts.

Lactic Acidosis

Lactic acidosis is characterized by elevated serum lactate (>4 mmol/L) and a low pH (<7.35). Its clinical presentation includes tachycardia, hypotension, tachypnea, and altered mental status. Unlike DKA, lactic acidosis often stems from tissue hypoperfusion (type A: shock, sepsis, hypoxia) or mitochondrial dysfunction (type B: drugs like metformin, liver failure, malignancies). The absence of hyperglycemia and ketonuria helps distinguish lactic acidosis from DKA, but in critically ill patients, both conditions can coexist. Measuring serum lactate and evaluating the anion gap are key. A high anion gap metabolic acidosis with a normal glucose concentration should prompt lactate testing.

Starvation Ketosis

Starvation ketosis occurs during prolonged fasting or very low carbohydrate intake. It typically produces mild ketonemia (serum ketones <3 mmol/L) and a slight increase in anion gap, but blood glucose remains normal or low, and pH rarely falls below 7.35. Patients may experience nausea and fatigue but rarely develop the severe acidosis or profound symptoms of DKA. Dietary history and lack of hyperglycemia quickly differentiate starvation ketosis from DKA.

Alcoholic Ketoacidosis

Alcoholic ketoacidosis (AKA) is seen in chronic alcohol abusers following a binge, often with poor nutritional intake. It presents with vomiting, abdominal pain, and deep respirations, closely mimicking DKA. Blood glucose in AKA is typically low or normal, not elevated. Serum ketones are strongly positive, and the anion gap is elevated. However, the patient may be hypoglycemic, and a history of heavy alcohol use with recent cessation of eating is a critical clue. Treatment involves dextrose and fluids; insulin is not needed unless hyperglycemia is present.

Key Differentiating Features at the Bedside

A structured approach using history, physical exam, and initial labs can differentiate DKA from other metabolic emergencies with high accuracy.

  • Blood Glucose Level: DKA typically presents with serum glucose between 250 and 600 mg/dL, while HHS is almost always >600 mg/dL. Lactic acidosis, AKA, and starvation ketosis usually have normal or low glucose.
  • Presence of Ketones: DKA shows high serum and urine ketones (beta-hydroxybutyrate >3 mmol/L). HHS has minimal to no ketones. Lactic acidosis may have slightly elevated ketones from stress, but rarely >1.5 mmol/L. AKA and starvation ketosis have moderate ketone elevations.
  • Serum pH and Bicarbonate: DKA causes a pH <7.30 with bicarbonate <15 mEq/L. HHS: pH >7.30, bicarbonate >15 mEq/L. Lactic acidosis: pH <7.35 often with bicarbonate <20 mEq/L, but can be severe (pH <7.1). AKA: pH may be low but often normalizes rapidly with treatment.
  • Anion Gap and Osmolality: DKA produces a high anion gap (usually >12) and moderately elevated osmolality (300–320 mOsm/kg). HHS has extremely high osmolality (>320 mOsm/kg) with a consistently elevated anion gap? Actually, HHS may have a minimally elevated anion gap due to slight lactate. Lactic acidosis: high anion gap with elevated lactate; osmolality normal unless other disease present.
  • Symptom Onset: DKA evolves over 12–24 hours; HHS over days to weeks; lactic acidosis can be acute (hours) in shock or subacute in drug-related cases.
  • Breath Odor: Fruity (acetone) is pathognomonic for DKA. Absent in HHS, lactic acidosis, and others.
  • Abdominal Pain: Common in DKA (up to 50%), also present in AKA and lactic acidosis. HHS rarely causes severe abdominal pain. Unexplained abdominal pain in a diabetic patient should always raise suspicion for DKA.

Laboratory Workup: Step-by-Step Differentiation

To confirm the diagnosis, clinicians must order a comprehensive metabolic panel, arterial or venous blood gas, serum lactate, serum ketones (preferably beta-hydroxybutyrate), and a complete blood count. Urinalysis for ketones and glucose provides rapid, though semiquantitative, data. The following decision algorithm helps differentiate the four most common high-anion-gap acidic emergencies (DKA, HHS, lactic acidosis, AKA):

  1. Check serum glucose. If >600 mg/dL, strongly consider HHS (or DKA with extreme hyperglycemia). If <250 mg/dL but with significant acidosis and ketones, consider euglycemic DKA or AKA.
  2. Calculate anion gap: Na - (Cl + HCO3). A gap >12 indicates metabolic acidosis. Then calculate the delta ratio (change in anion gap divided by change in bicarbonate) or Winters' formula to assess compensatory response.
  3. Measure serum lactate. If lactate >4 mmol/L, lactic acidosis is likely primary or coexisting. If lactate <2 and gap is elevated, move to ketone evaluation.
  4. Assess ketones. Beta-hydroxybutyrate >3 mmol/L strongly supports DKA or AKA. AKA patients usually have lower glucose and an alcohol history. DKA patients have hyperglycemia.
  5. Evaluate for other causes: Toxic alcohols (methanol, ethylene glycol) produce osmolal gaps with high anion gap acidosis. Check osmolal gap and serum osmolarity. If gap >10 mOsm, suspect toxic alcohol poisoning.

Clinical Pearls for Emergency Differentiation

In the busy emergency department, time is critical. The following practical tips help avoid misdiagnosis:

  • Always obtain a beta-hydroxybutyrate level instead of urine dipstick ketones. Urine strips detect acetoacetate but not the predominant ketone, beta-hydroxybutyrate, which can lead to false negatives early in DKA.
  • Beware of normal glucose DKA in patients on SGLT2 inhibitors (empagliflozin, dapagliflozin, canagliflozin). These patients may present with severe acidosis despite glucose <200 mg/dL. Check ketones and pH whenever they have unexplained nausea/vomiting.
  • In a known diabetic with altered mental status, check serum osmolality. If >330 mOsm/kg, HHS is more likely than DKA. However, mixed DKA/HHS occurs in up to 30% of hyperglycemic crises.
  • Don't rely on the presence of abdominal pain as a sole indicator for surgery. Peritoneal signs from DKA can mimic appendicitis or perforation but resolve with fluid and insulin therapy.
  • Consider uremic acidosis in patients with renal failure presenting with metabolic acidosis. Uremia produces an anion gap from phosphate and sulfate accumulation, but glucose and lactate are usually normal.

Treatment Implications Based on Differentiation

Misdiagnosing DKA as HHS can lead to potentially dangerous insulin overdose and hypokalemia. Conversely, treating HHS with aggressive insulin before rehydration can cause catastrophic brain edema. The table below summarizes initial management strategies:

DKA: Start with IV fluids (0.9% saline), potassium replacement, and insulin infusion (0.1 U/kg IV bolus followed by 0.1 U/kg/h). Monitor glucose, pH, and potassium every 1–2 hours. If euglycemic DKA, continue insulin and fluids while adding dextrose once glucose <250 mg/dL.
HHS: Aggressive volume resuscitation (4–6 L of 0.9% saline initially) before insulin. Insulin infusion started at 0.05–0.1 U/kg/h once glucose stops declining with fluids. Goal: gradual glucose decline of 50–70 mg/dL per hour. Avoid overcorrection of hypertonicity.
Lactic acidosis: Treat the underlying cause (sepsis, hypoxia, toxin). Sodium bicarbonate is rarely indicated except in severe acidosis (pH <7.1) with cardiac instability. Avoid insulin unless hyperglycemia is present.
AKA: Administer IV fluids with dextrose (D5NS) to stimulate endogenous insulin secretion and suppress ketogenesis. Thiamine supplementation prevents Wernicke's encephalopathy. Insulin is not needed unless glucose is elevated.

When Both Conditions Coexist: Mixed DKA, HHS, and Lactic Acidosis

Critically ill patients with diabetes may simultaneously meet criteria for DKA and HHS (mixed hyperglycemic crisis) or have superimposed lactic acidosis (e.g., in sepsis). The diagnosis of mixed DKA/HHS is made when the patient has severe hyperglycemia (>600 mg/dL) and significant acidosis (pH <7.30, bicarbonate <15, ketones present). These patients require a combination strategy: aggressive rehydration as in HHS plus insulin infusion and potassium replacement as in DKA. For lactic acidosis, serial lactate levels guide therapy; the priority is reversing the shock state. Early consultation with an intensivist or endocrinologist is advisable for complex cases.

Case Example: A Practical Walkthrough

A 45-year-old woman with type 2 diabetes (on metformin and empagliflozin) presents with 12 hours of nausea, vomiting, and deep, rapid breathing. Her point-of-care glucose is 180 mg/dL. Initial labs show: pH 7.22, bicarbonate 10, anion gap 18, lactate 1.2, and beta-hydroxybutyrate 5.5 mmol/L. Urine ketones are large. She has no history of alcohol use. Her serum osmolality is 295 mOsm/kg.

Differentiation: Despite normoglycemia, the combination of high ketones, low pH, low bicarbonate, and elevated anion gap confirms euglycemic DKA. The absence of hyperosmolality and lack of elevated lactate rule out HHS and lactic acidosis. Her SGLT2 inhibitor is identified as the likely trigger. She is treated with IV saline and insulin with dextrose. Her symptoms resolve within 18 hours. This case underscores the importance of checking ketones and pH in diabetics on SGLT2 inhibitors even without hyperglycemia.

Long-Term Implications and Follow-Up

Once the acute crisis is managed, addressing the underlying cause is crucial to prevent recurrence. For DKA, this includes assessing insulin adherence, infection, or new-onset diabetes. In HHS, improving glycemic control and managing comorbidities (e.g., cardiovascular disease, infection) reduces risk. For patients with lactic acidosis, evaluating for occult sepsis, metformin accumulation (especially if renal impairment), or malignancy may be necessary. All patients with a hyperglycemic emergency should receive diabetes education, medication review (including SGLT2 inhibitor counseling), and follow-up with an endocrinologist. Documentation of the specific type of metabolic disorder and its trigger helps ensure appropriate long-term management.

Conclusion

Differentiating diabetic ketoacidosis from hyperosmolar hyperglycemic state, lactic acidosis, alcoholic ketoacidosis, and starvation ketosis is a critical skill for clinicians at every level. While symptom overlap exists, a methodical assessment of glucose level, ketone presence, blood pH, anion gap, and clinical history reliably distinguishes these entities. The use of advanced point-of-care tests such as beta-hydroxybutyrate and blood gas analysis enables early, accurate diagnosis even in atypical presentations like euglycemic DKA. Correct differentiation not only guides immediate life-saving therapy—insulin versus fluids versus dextrose—but also prevents iatrogenic complications. As the prevalence of diabetes and use of SGLT2 inhibitors rises, maintaining a high index of suspicion for DKA in patients with metabolic acidosis, regardless of glucose level, is more important than ever.

External resources: